NeurOp Corporation Announces Drug Discovery Collaboration with Bristol-Myers Squibb Company
ATLANTA--(BUSINESS WIRE)--NeurOp Corporation today announced a collaboration with Bristol-Myers Squibb Company (NYSE: BMY) focused upon the development of NeurOp’s proprietary small molecules for use in the treatment of major depression and other central nervous system disorders.